Agilent Technologies on Wednesday announced a multiyear distribution agreement with Proscia to offer a comprehensive digital diagnostic pathology system.
Combining Agilent’s pathology staining solutions with Proscia’s Concentriq Dx* enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes, Agilent said.
*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency.
Featured Story:
Latest Articles
March 5, 2024
February 27, 2024